Evidence map›Paper›PMID 42057918›Full record

ReviewCurrent research in parasitology & vector-borne diseases2026

Revisiting visceral leishmaniasis in immunocompromised patients: Ongoing gaps and advances in diagnostics, therapies, and preventive measures.

Soroush Partovi Moghaddam, Iraj Sharifi, Narges Lotfalizadeh, Shayan Amini, Ali Mobaraki, Bita Fazel, Mehdi Bamorovat, Ahmad Khosravi, Baharak Akhtardanesh, Mehdi Mohebali

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current research in parasitology & vector-borne diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Soroush Partovi MoghaddamDepartment of Pathobiology, Faculty of Veterinary Specialized Science, Science, and Research Branch, Islamic Azad University, Tehran, Iran.
Iraj SharifiLeishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Narges LotfalizadehDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Shayan AminiShahid Beheshti Medical University, Tehran, Iran.
Ali MobarakiShahid Beheshti Medical University, Tehran, Iran.
Bita FazelFaculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Mehdi BamorovatLeishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Ahmad KhosraviLeishmaniasis Research Center, Kerman University of Medical Sciences, Kerman, Iran.
Baharak AkhtardaneshDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.
Mehdi MohebaliDepartment of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The visceral leishmaniasis (VL) caused by

Indexed as

DiagnosisHIV/AIDSImmunosuppressionOrgan transplantationPreventive measuresTreatmentVisceral leishmaniasis

Identifiers

PMID42057918
PMCPMC13123496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.